Aetna policies, page 7

Search Aetna's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Aetna, by title.

Aetna policies
PolicyDetailsCodesSource
0888-Orthopedic Implant Movement Analysis0888 · Commercial4Original policy ↗
0889-Levoleucovorin (Khapzory)0889 · Commercial12Original policy ↗
0890-Pembrolizumab Products (Keytruda and Keytruda Qlex)0890 · Commercial82Original policy ↗
0891-Blinatumomab (Blincyto)0891 · Commercial5Original policy ↗
0892-Nivolumab Products (Opdivo, Opdivo Qvantig, and Opdualag)0892 · Commercial58Original policy ↗
0893-Leadless Cardiac Pacemaker0893 · Commercial38Original policy ↗
0895-Dinutuximab (Unituxin)0895 · Commercial7Original policy ↗
0896-Chemical Aversive Conditioning for Alcoholism0896 · Commercial—Original policy ↗
0897-Mepolizumab (Nucala)0897 · Commercial38Original policy ↗
0898-Necitumumab (Portrazza)0898 · Commercial8Original policy ↗
0899-Elotuzumab (Empliciti)0899 · Commercial11Original policy ↗
0900-Talimogene Laherparepvec (Imlygic)0900 · Commercial10Original policy ↗
0901-Asfotase alfa (Strensiq)0901 · Commercial12Original policy ↗
0902-Irinotecan Liposome Injection (Onivyde)0902 · Commercial21Original policy ↗
0903-Trabectedin (Yondelis)0903 · Commercial7Original policy ↗
0904-Daratumumab (Darzalex) and Daratumumab and Hyaluronidase-fihj (Darzalex Faspro)0904 · Commercial39Original policy ↗
0905-Secukinumab (Cosentyx)0905 · Commercial39Original policy ↗
0906-Ostomy Supplies0906 · Commercial99Original policy ↗
0907-Reslizumab (Cinqair)0907 · Commercial38Original policy ↗
0910-Extended-Release Buprenorphine Injectables0910 · Commercial20Original policy ↗
0912-Ustekinumab0912 · Commercial61Original policy ↗
0914-Bezlotoxumab (Zinplava)0914 · Commercial3Original policy ↗
0915-Nusinersen (Spinraza)0915 · Commercial30Original policy ↗
0916-Avelumab (Bavencio)0916 · Commercial10Original policy ↗
0917-Durvalumab (Imfinzi)0917 · Commercial41Original policy ↗
0918-Edaravone Injection0918 · Commercial3Original policy ↗
0919-Inotuzumab Ozogamicin (Besponsa)0919 · Commercial22Original policy ↗
0920-Tisagenlecleucel (Kymriah)0920 · Commercial9Original policy ↗
0921-Daunorubicin-Cytarabine Liposome (Vyxeos)0921 · Commercial4Original policy ↗
0922-Gemtuzumab Ozogamicin (Mylotarg)0922 · Commercial5Original policy ↗
0924-Axicabtagene Ciloleucel (Yescarta)0924 · Commercial7Original policy ↗
0925-Benralizumab (Fasenra)0925 · Commercial46Original policy ↗
0926-Transperineal Placement of Biodegradable Material for Prostate Cancer0926 · Commercial6Original policy ↗
0927-Voretigene Neparvovec-rzyl (Luxturna)0927 · Commercial14Original policy ↗
0928-Optical Coherence Tomography of the Head and Neck0928 · Commercial4Original policy ↗
0929-Lutetium Lu Dotatate (Lutathera) and Lutetium Lu 177 Vipivotide Tetraxetan (Pluvicto)0929 · Commercial37Original policy ↗
0930-Cardiac Contractility Modulation (CCM) Therapy0930 · Commercial27Original policy ↗
0933-Pegvaliase-pqpz (Palynziq)0933 · Commercial2Original policy ↗
0934-Epidural Injection Technologies0934 · Commercial12Original policy ↗
0935-Mometasone furoate sinus implant (Sinuva)0935 · Commercial5Original policy ↗
0936-Ibalizumab-uiyk (Trogarzo)0936 · Commercial12Original policy ↗
0937-Sinus Surgeries0937 · Commercial61Original policy ↗
0938-Ketamine for the Treatment of Depression and Other Selected Indications0938 · Commercial3Original policy ↗
0939-Transthyretin-Mediated (ATTR) Amyloidosis0939 · Commercial25Original policy ↗
0940-Mogamulizumab-kpkc (Poteligeo)0940 · Commercial19Original policy ↗
0942-Cemiplimab (Libtayo)0942 · Commercial10Original policy ↗
0944-Sufentanil Sublingual Tablet (Dsuvia)0944 · Commercial—Original policy ↗
0945-Vitamin D Assay0945 · Commercial3Original policy ↗
0946-Ravulizumab-cwvz (Ultomiris)0946 · Commercial28Original policy ↗
0947-Tagraxofusp-erzs (Elzonris)0947 · Commercial3Original policy ↗

Back to Aetna · Aetna prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.